latest news releases from the newsroom
Savient Pharmaceuticals Inc
Savient to Present Multiple Abstracts At the European League Against Rheumatism (EULAR) 2009 Annual Congress
EAST BRUNSWICK, N.J., May 29, 2009 (GLOBE NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) announced today that six abstracts (two oral presentations and four posters) about the Company's product candidate KRYSTEXXA(tm) (pegloticase) will be presented at the European League Against Rheumatism (EULAR) 2009 Annual Congress June 10-13 in Copenhagen, Denmark addressing various aspects of treatment failure gout. Treatment failure gout occurs in patients with gout who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with urate-lowering therapy at the maximum medically appropriate dose or for whom those drugs are contraindicated.
PIMCO Municipal Advantage Fund
PIMCO Municipal Advantage Fund Inc. Announces Record and Payment Dates for Partial Liquidating Distribution and Terminates Monthly Dividend
NEW YORK, May 29, 2009 (GLOBE NEWSWIRE) -- PIMCO Municipal Advantage Fund Inc. (NYSE:MAF) (the "Fund") announced today that a partial liquidating distribution of $6.20 per common share will be paid on June 30, 2009, with a record date of June 26, 2009 and an ex-dividend date of June 24, 2009. This will be the first of two expected liquidating distributions of the Fund's common stock in connection with the liquidation of the Fund, which was communicated in a press release dated March 17, 2009. The number of outstanding Fund shares will not be decreased as a result of this partial liquidating distribution, which will be made entirely in cash.